Literature DB >> 9114418

Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains.

T Kitamura1, C Sugimoto, A Kato, H Ebihara, M Suzuki, F Taguchi, K Kawabe, Y Yogo.   

Abstract

The polyomavirus JC virus (JCV), the causative agent of progressive multifocal leukoencephalopathy, is ubiquitous in the human population, infecting children asymptomatically. JCV is often detected in normal renal tissue and in the urine of healthy individuals. We demonstrate that renal JCV represents that which persists after primary infection.

Entities:  

Mesh：

Year:  1997        PMID： 9114418      PMCID： PMC232740          DOI： 10.1128/jcm.35.5.1255-1257.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis.

Authors:  M Mori; N Aoki; H Shimada; M Tajima; K Kato
Journal:  Neurosci Lett       Date:  1992-07-20       Impact factor: 3.046

2.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

3.  Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

4.  Evidence of human polyomavirus BK and JC infection in normal brain tissue.

Authors:  C Elsner; K Dörries
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

5.  JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Authors:  F A White; M Ishaq; G L Stoner; R J Frisque
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals.

Authors:  K Dörries; E Vogel; S Günther; S Czub
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

7.  Transmission of the human polyomavirus JC virus occurs both within the family and outside the family.

Authors:  T Kitamura; T Kunitake; J Guo; T Tominaga; K Kawabe; Y Yogo
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients.

Authors:  T Tominaga; Y Yogo; T Kitamura; Y Aso
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

9.  JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.

Authors:  M C Monaco; W J Atwood; M Gravell; C S Tornatore; E O Major
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Subclinical central nervous system infection with JC virus in patients with AIDS.

Authors:  E B Quinlivan; M Norris; T W Bouldin; K Suzuki; R Meeker; M S Smith; C Hall; S Kenney
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226
View more
  26 in total

1.  Typing of urinary JC virus DNA offers a novel means of tracing human migrations.

Authors:  C Sugimoto; T Kitamura; J Guo; M N Al-Ahdal; S N Shchelkunov; B Otova; P Ondrejka; J Y Chollet; S El-Safi; M Ettayebi; G Grésenguet; T Kocagöz; S Chaiyarasamee; K Z Thant; S Thein; K Moe; N Kobayashi; F Taguchi; Y Yogo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays.

Authors:  Luis Del Valle; Kamel Khalili
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

Review 3.  From Evolutionary Advantage to Disease Agents: Forensic Reevaluation of Host-Microbe Interactions and Pathogenicity.

Authors:  Jessica I Rivera-Pérez; Alfredo A González; Gary A Toranzos
Journal:  Microbiol Spectr       Date:  2017-01

4.  Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy.

Authors:  D García de Viedma; R Alonso; P Miralles; J Berenguer; M Rodriguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage.

Authors:  S Bofill-Mas; S Pina; R Girones
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

Review 6.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

8.  Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen.

Authors:  K Hara; C Sugimoto; T Kitamura; N Aoki; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Asian genotypes of JC virus in Japanese-Americans suggest familial transmission.

Authors:  Makoto Suzuki; Huai-Ying Zheng; Tomokazu Takasaka; Chie Sugimoto; Tadaichi Kitamura; Ernest Beutler; Yoshiaki Yogo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy.

Authors:  Atsushi Kato; Tadaichi Kitamura; Tomokazu Takasaka; Takashi Tominaga; Akira Ishikawa; Huai-Ying Zheng; Yoshiaki Yogo
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.